CRP and inflammatory bowel disease: However, in clinical trials, clinical scores are preferred metrics over biomarkers such as FCP and serum CRP because, while biomarkers are useful indicators to infer endoscopically active IBD, their levels do not necessarily correlate with disease activity level (Falvey et al., 2015; Wagatsuma et al., 2021).